{"database": "open_comments", "table": "open_comments_active", "is_view": true, "human_description_en": "", "rows": [["IRS-2025-0013-0001", "IRS", "IRS-2025-0013", "Announcement 2025-6", "Notice", "Announcement", "2025-01-15", 2025, 1, "2025-01-15", "2027-01-15", "2027-01-16 04:59:59", 0, "2025-10-13 09:00:11", null, 1, 0, "09000064868c30ce"], ["HHS-OPHS-2018-0025-0001", "HHS", "HHS-OPHS-2018-0025", "Posting Requirement for the Exemption at 45 CFR 46.104(d)(5) of the 2018 Requirements (2022)", "Other", null, "2022-06-15", 2022, 6, "2022-06-27", "2032-06-30", "2032-07-01 03:59:59", 0, "2026-04-27 09:00:11", null, 1, 0, "0900006485164c0a"], ["EPA-HQ-OPP-2023-0288-0008", "EPA", "EPA-HQ-OPP-2023-0288", "Guidance: Pesticides; Evaluation of Products for Claims against Viruses", "Notice", null, "2024-10-10", 2024, 10, "2024-10-10", "2032-10-10", "2032-10-11 03:59:59", 0, "2026-05-07 09:00:17", "2024-23471", 1, 0, "09000064867c4202"], ["FDA-2011-N-0655-0041", "FDA", "FDA-2011-N-0655", "Animal Generic Drug User Fee Act; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2026-04-17", 2026, 4, "2026-04-17", "2027-12-01", "2027-12-02 04:59:59", 0, "2026-07-01 09:00:24", "2026-07497", 1, 0, "09000064b928930a"], ["FDA-2026-N-0131-0001", "FDA", "FDA-2026-N-0131", "FDA Rare Disease Innovation Hub Future Programming; Request for Comments", "Notice", "Request for Comments", "2026-01-30", 2026, 1, "2026-01-30", "2026-12-31", "2027-01-01 04:59:59", 0, "2026-07-08 09:00:11", "2026-01903", 1, 0, "09000064b91893ee"], ["FHWA-2026-0826-0001", "FHWA", "FHWA-2026-0826", "Environmental Impact Statements; Availability, etc.: Washington County, ME", "Notice", "Notice of Intent", "2026-07-09", 2026, 7, "2026-07-09", "2026-10-31", "2026-11-01 03:59:59", 0, "2026-07-09 17:07:02", "2026-13876", 1, 0, "09000064b9376458"], ["FAA-2026-7210-0001", "FAA", "FAA-2026-7210", "Intent to Designate as Abandoned: Abandoned Javelin Conversions, Inc. Supplemental Type Certificates", "Notice", "Request for Comments", "2026-07-08", 2026, 7, "2026-07-08", "2027-01-04", "2027-01-05 04:59:59", 0, "2026-07-14 09:00:28", "2026-13723", 1, 0, "09000064b9370750"], ["FDA-2026-N-7864-0001", "FDA", "FDA-2026-N-7864", "Data Request (DR001): Use of the pH Cycling Test Model as a Testing Procedure for Fluoride Dentifrice Drug Products in Over-the-Counter (OTC) Monograph M021: Anticaries Drug Products for Over-the-Counter Human Use", "Other", "Request", "2026-07-28", 2026, 7, "2026-07-28", "2027-01-25", "2027-01-26 04:59:59", 0, "2026-07-28 16:50:16", null, 1, 0, "09000064b93c7444"], ["NCUA-2026-1420-0001", "NCUA", "NCUA-2026-1420", "Great Horizons Federal Credit Union - Disclaimer", "Notice", null, "2026-07-29", 2026, 7, "2026-08-05", "2026-10-08", "2026-10-09 03:59:59", 0, "2026-07-29 19:40:35", null, 1, 0, "09000064b93d6ce0"], ["ITC-2026-4258-0001", "ITC", null, "Investigations; Determinations, Modifications, and Rulings, etc.: Certain Seamless Carbon and Alloy Steel Standard, Line, and Pressure Pipe from China", "Notice", null, "2026-08-03", 2026, 8, "2026-08-03", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-03 16:26:42", "2026-15646", 1, 0, "09000064b93e9d48"], ["BIA-2022-0005-0024", "BIA", "BIA-2022-0005", "Agency Information Collection Activities; Education Contracts Under the Johnson-O'Malley Act", "Notice", null, "2026-01-22", 2026, 1, "2026-01-21", "2027-03-31", "2027-04-01 03:59:59", 0, "2026-08-04 23:28:41", "2026-01179", 1, 0, "09000064b9179f6a"], ["IRS-2026-0496-0001", "IRS", "IRS-2026-0496", "Guidance on the employer credit for paid family and medical leave under section 45S (Notice 2026-28)", "Notice", "Notice of Publication", "2026-08-05", 2026, 8, "2026-08-05", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-05 19:40:14", null, 1, 0, "09000064b940001a"], ["FCC-2026-3072-0001", "FCC", null, "Build America: Eliminating Barriers to Wireline Deployments", "Proposed Rule", null, "2026-08-07", 2026, 8, "2026-08-07", "2026-11-05", "2026-11-06 04:59:59", 0, "2026-08-07 16:26:39", "2026-16196", 1, 0, "09000064b9416ef1"], ["FDA-2025-E-0707-0005", "FDA", "FDA-2025-E-0707", "Determination of Regulatory Review Period for Purposes of Patent Extension; DAYVIGO", "Notice", "Determinations", "2026-08-10", 2026, 8, "2026-08-10", "2026-10-09", "2026-10-10 03:59:59", 0, "2026-08-10 17:44:43", "2026-16246", 1, 0, "09000064b94289c5"], ["FCC-2026-3137-0001", "FCC", null, "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-11", 2026, 8, "2026-08-11", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-11 16:26:39", "2026-16298", 1, 0, "09000064b942eb47"], ["EPA-HQ-OPPT-2015-0436-0048", "EPA", "EPA-HQ-OPPT-2015-0436", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions from Testing Requirement (Renewal)", "Notice", "Information Collection Request (ICR)", "2026-08-11", 2026, 8, "2026-08-11", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-11 16:45:13", "2026-16311", 1, 0, "09000064b942eba1"], ["NARA_FRDOC_0001-1137", "NARA", "NARA_FRDOC_0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-12", 2026, 8, "2026-08-12", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-12 16:25:45", "2026-16378", 1, 0, "09000064b9436a4c"], ["CMS-2026-2740-0001", "CMS", "CMS-2026-2740", "Electronic Funds Transfer Authorization Agreement (CMS-588)", "Notice", null, "2026-08-12", 2026, 8, "2026-08-12", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-12 18:14:49", "2026-16386", 1, 0, "09000064b9436ab0"], ["NCUA-2026-1520-0001", "NCUA", "NCUA-2026-1520", "NRS Community Development Federal Credit Union - Disclaimer", "Notice", null, "2026-08-12", 2026, 8, "2026-08-31", "2026-11-08", "2026-11-09 04:59:59", 0, "2026-08-12 19:09:32", null, 1, 0, "09000064b9437da7"], ["FDA-2011-N-0656-1315", "FDA", "FDA-2011-N-0656", "Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder\nIntent To Participate", "Notice", "General Notice", "2026-05-11", 2026, 5, "2026-05-11", "2027-12-01", "2027-12-02 04:59:59", 0, "2026-08-13 14:40:33", "2026-09283", 1, 0, "09000064b92cacd0"], ["FDA-2011-N-0655-0042", "FDA", "FDA-2011-N-0655", "Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for\nNotification of Stakeholder Intent To Participate", "Notice", "Notice of Intent", "2026-05-11", 2026, 5, "2026-05-11", "2027-12-01", "2027-12-02 04:59:59", 0, "2026-08-13 14:41:39", "2026-09284", 1, 0, "09000064b92cf91b"], ["CMS-2026-2773-0001", "CMS", "CMS-2026-2773", "Quality Bonus Payment Appeals (CMS-10346)", "Notice", null, "2026-08-13", 2026, 8, "2026-08-13", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-13 19:28:46", "2026-16455", 1, 0, "09000064b943bb72"], ["USA-2026-HQ-0562-0001", "USA", "USA-2026-HQ-0562", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-13", 2026, 8, "2026-08-13", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-14 17:18:13", "2026-16530", 1, 0, "09000064b9436b87"], ["FCC-2026-3202-0001", "FCC", null, "Review of E-Rate Program to Ensure Congress's Vision", "Proposed Rule", null, "2026-08-14", 2026, 8, "2026-08-14", "2026-11-12", "2026-11-13 04:59:59", 0, "2026-08-14 19:25:18", "2026-16590", 1, 0, "09000064b945712e"], ["FCC-2026-3203-0001", "FCC", null, "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-14", 2026, 8, "2026-08-14", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-14 19:25:21", "2026-16556", 1, 0, "09000064b9457132"], ["FS_FRDOC_0001-4420", "FS", "FS_FRDOC_0001", "Requests for Nominations: Secure Rural Schools Resource Advisory Committees", "Notice", null, "2026-08-14", 2026, 8, "2026-08-14", "2026-11-12", "2026-11-13 04:59:59", 0, "2026-08-14 19:25:23", "2026-16656", 1, 0, "09000064b94571f5"], ["CFTC-2026-1783-0001", "CFTC", "CFTC-2026-1783", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-14", 2026, 8, "2026-08-14", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-14 19:25:25", "2026-16631", 1, 0, "09000064b94572fd"], ["FERC-2026-4828-0001", "FERC", null, "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-14", 2026, 8, "2026-08-14", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-14 19:25:25", "2026-16653", 1, 0, "09000064b9457392"], ["FRA-2026-1585-0001", "FRA", "FRA-2026-1585", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Request for Comments", "2026-08-14", 2026, 8, "2026-08-14", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-14 19:25:25", "2026-16593", 1, 0, "09000064b9457347"], ["FRA-2026-0039-0001", "FRA", "FRA-2026-0039", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Request for Comments", "2026-08-14", 2026, 8, "2026-08-14", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-14 19:31:03", "2026-16592", 1, 0, "09000064b944e8ab"], ["EPA-HQ-OPPT-2025-2433-0001", "EPA", "EPA-HQ-OPPT-2025-2433", "2026 Unified Agenda of Regulatory and Deregulatory Actions", "Notice", null, "2026-08-14", 2026, 8, "2026-08-14", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-15 09:01:35", "2026-16608", 1, 0, "09000064b9457348"], ["VA-2026-VACO-0001-0328", "VA", "VA-2026-VACO-0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application for Assumption Approval and/or Release from Personal Liability to the Government on a Home Loan [FR Doc No: 2026-16501; OMB Control No. 2900-0110]", "Notice", null, "2026-08-13", 2026, 8, "2026-08-13", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-17 09:00:53", "2026-16501", 1, 0, "09000064b943bb78"], ["VA-2026-VACO-0001-0329", "VA", "VA-2026-VACO-0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Mandatory Verification of Dependents [FR Doc No: 2026-16500; OMB Control No. 2900-0500]", "Notice", null, "2026-08-13", 2026, 8, "2026-08-13", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-17 09:00:53", "2026-16500", 1, 0, "09000064b9436b88"], ["FISCAL_FRDOC_0001-0309", "FISCAL", "FISCAL_FRDOC_0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Annual Financial Statement of Surety Companies\u2014Schedule F", "Notice", null, "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 16:25:56", "2026-16725", 1, 0, "09000064b9462d0d"], ["FISCAL_FRDOC_0001-0310", "FISCAL", "FISCAL_FRDOC_0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Authorization Agreement for Preauthorized Payment", "Notice", null, "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 16:26:07", "2026-16726", 1, 0, "09000064b9462d58"], ["NHTSA-2026-1651-0001", "NHTSA", "NHTSA-2026-1651", "New Car Assessment Program: Removal of Dynamic Rollover Resistance Test and Side Air Bag Out-of-Position Testing; Updates to NCAP's 10-Year Roadmap", "Notice", "Request for Comments", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 16:36:20", "2026-16735", 1, 0, "09000064b9461c63"], ["FDA-2026-N-7757-0001", "FDA", "FDA-2026-N-7757", "Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food", "Notice", "60 Day Proposed Information Collection", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 17:13:22", "2026-16714", 1, 0, "09000064b9462da6"], ["FDA-2026-N-8328-0001", "FDA", "FDA-2026-N-8328", "Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries", "Notice", "60 Day Proposed Information Collection", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 17:48:14", "2026-16712", 1, 0, "09000064b9462da4"], ["FDA-2025-E-0490-0005", "FDA", "FDA-2025-E-0490", "Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI", "Notice", "Determinations", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 18:05:29", "2026-16713", 1, 0, "09000064b9462d5b"], ["FDA-2025-E-0485-0005", "FDA", "FDA-2025-E-0485", "Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI", "Notice", "Determinations", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 18:06:12", "2026-16713", 1, 0, "09000064b9463d3f"], ["FDA-2025-E-0486-0005", "FDA", "FDA-2025-E-0486", "Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI", "Notice", "Determinations", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 18:06:44", "2026-16713", 1, 0, "09000064b9463d40"], ["FDA-2025-E-0488-0005", "FDA", "FDA-2025-E-0488", "Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI", "Notice", "Determinations", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 18:07:20", "2026-16713", 1, 0, "09000064b9463d41"], ["FDA-2025-E-0489-0005", "FDA", "FDA-2025-E-0489", "Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI", "Notice", "Determinations", "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 18:07:39", "2026-16713", 1, 0, "09000064b9463d42"], ["OPM-2026-0134-0042", "OPM", "OPM-2026-0134", "Privacy Act; Re-Established Matching Program", "Notice", null, "2026-08-06", 2026, 8, "2026-08-06", "2026-10-27", "2026-10-28 03:59:59", 0, "2026-08-17 18:58:03", "2026-15940", 1, 0, "09000064b9407cd1"], ["DARS-2026-0364-0001", "DARS", "DARS-2026-0364", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Defense Federal Acquisition Regulation Supplement, DoD Mentor-Protege Program", "Notice", null, "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-17 19:11:31", "2026-16682", 1, 0, "09000064b9462d14"], ["DEA-2022-0002-0008", "DEA", "DEA-2022-0002", "Exempt Chemical Preparations Aug 2026 (2026-16665) - DEA372", "Notice", null, "2026-08-17", 2026, 8, "2026-08-17", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-17 21:26:45", "2026-16665", 1, 0, "09000064b946485f"], ["BOEM-2026-0926-0001", "BOEM", "BOEM-2026-0926", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Negotiated Noncompetitive Agreements for the Use of Outer Continental Shelf Sand, Gravel, and/or Shell Resources", "Notice", null, "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-18 09:01:12", "2026-16684", 1, 0, "09000064b9461cb0"], ["USBC-2026-0430-0001", "USBC", "USBC-2026-0430", "CoG 60dayfrn_published_081826", "Notice", null, "2026-08-18", 2026, 8, "2026-08-18", "2026-10-18", "2026-10-19 03:59:59", 0, "2026-08-18 17:03:09", "2026-16791", 1, 0, "09000064b9467195"], ["FDA-2017-D-5974-0012", "FDA", "FDA-2017-D-5974", "Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability", "Notice", "Determinations", "2026-08-18", 2026, 8, "2026-08-18", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-18 17:24:50", "2026-16837", 1, 0, "09000064b9467538"], ["FDA-2026-N-7914-0001", "FDA", "FDA-2026-N-7914", "Public Meeting on Listeria monocytogenes Prevention", "Other", "Additional Information", "2026-08-03", 2026, 8, "2026-08-03", "2026-11-02", "2026-11-03 04:59:59", 0, "2026-08-19 09:01:12", null, 1, 0, "09000064b93e5b66"], ["FDIC-2026-1486-0001", "FDIC", null, "Community Reinvestment Act Regulations", "Proposed Rule", null, "2026-08-12", 2026, 8, "2026-08-12", "2026-10-13", "2026-10-14 03:59:59", 0, "2026-08-19 16:25:21", "2026-16454", 1, 0, "09000064b9436b80"], ["DOL_FRDOC_0001-2697", "DOL", "DOL_FRDOC_0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-19", 2026, 8, "2026-08-19", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-19 16:39:59", "2026-16880", 1, 0, "09000064b946a963"], ["OPM_FRDOC_0001-4615", "OPM", "OPM_FRDOC_0001", "Privacy Act; Matching Program", "Notice", null, "2026-08-19", 2026, 8, "2026-08-19", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-19 16:40:05", "2026-16849", 1, 0, "09000064b946a998"], ["DOD-2026-OS-1684-0001", "DOD", "DOD-2026-OS-1684", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-19", 2026, 8, "2026-08-19", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-19 18:36:14", "2026-16920", 1, 0, "09000064b946a9d7"], ["FDA-2011-N-0656-1314", "FDA", "FDA-2011-N-0656", "Animal Drug User Fee Act; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2026-04-17", 2026, 4, "2026-04-17", "2027-12-01", "2027-12-02 04:59:59", 0, "2026-08-20 09:01:12", "2026-07498", 1, 0, "09000064b928948d"], ["EIB-2026-0232-0001", "EIB", "EIB-2026-0232", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Notice of Claim and Proof of Loss, Working Capital Guarantee", "Notice", null, "2026-08-18", 2026, 8, "2026-08-18", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-20 09:01:26", "2026-16845", 1, 0, "09000064b94653e1"], ["AMS-NOP-26-1321-0001", "AMS", "AMS-NOP-26-1321", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: National Organic Program; Strengthening Organic Enforcement", "Notice", "60 Day Proposed Information Collection", "2026-08-19", 2026, 8, "2026-08-19", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-20 09:01:27", "2026-16910", 1, 0, "09000064b946aa25"], ["FCC-2026-3268-0001", "FCC", null, "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-20", 2026, 8, "2026-08-20", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-20 16:26:27", "2026-16993", 1, 0, "09000064b946aac1"], ["STB-2026-2312-0001", "STB", null, "Control: Union Pacific Corp. and Union Pacific Railroad Co., Norfolk Southern Corp. and Norfolk Southern Railway Co.", "Notice", null, "2026-08-20", 2026, 8, "2026-08-20", "2027-03-29", "2027-03-30 03:59:59", 0, "2026-08-20 16:26:53", "2026-17024", 1, 0, "09000064b946c86d"], ["FCC-2026-3270-0001", "FCC", null, "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-20", 2026, 8, "2026-08-20", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-20 16:27:26", "2026-16996", 1, 0, "09000064b946c8b7"], ["FCC-2026-3271-0001", "FCC", null, "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", null, "2026-08-20", 2026, 8, "2026-08-20", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-20 16:27:51", "2026-16997", 1, 0, "09000064b946e17f"], ["NSF_FRDOC_0001-3629", "NSF", "NSF_FRDOC_0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Improving Customer Experience", "Notice", null, "2026-08-20", 2026, 8, "2026-08-20", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-20 16:27:53", "2026-16984", 1, 0, "09000064b946e1c2"], ["FDA-2026-D-8561-0001", "FDA", "FDA-2026-D-8561", "Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-08-20", 2026, 8, "2026-08-20", "2026-11-18", "2026-11-19 04:59:59", 0, "2026-08-20 17:54:40", "2026-16960", 1, 0, "09000064b946c7f3"], ["FDA-2026-D-8561-0002", "FDA", "FDA-2026-D-8561", "Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry", "Other", "Guidance", "2026-08-20", 2026, 8, "2026-08-20", "2026-11-18", "2026-11-19 04:59:59", 0, "2026-08-20 17:59:44", null, 1, 0, "09000064b946ee4d"], ["FCC-2026-3301-0001", "FCC", null, "Radio Broadcasting Services: AM or FM Proposals to Change the Community of License", "Notice", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 16:25:50", "2026-17160", 1, 0, "09000064b9473727"], ["SEC-2026-5190-0001", "SEC", null, "Regulation Crypto Assets", "Proposed Rule", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 16:27:47", "2026-17183", 1, 0, "09000064b94738fa"], ["RITA-2026-0001-0001", "RITA", "RITA-2026-0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Intermodal Freight Facilities Air-to-Truck and Mail Cargo Geospatial Data Update", "Notice", "Request for Comments", "2026-08-20", 2026, 8, "2026-08-20", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-21 16:27:55", "2026-17000", 1, 0, "09000064b946e138"], ["FEMA-2026-0002-0051", "FEMA", "FEMA-2026-0002", "Proposed Flood Hazard Determinations", "Notice", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-11-19", "2026-11-20 04:59:59", 0, "2026-08-21 17:01:46", "2026-17076", 1, 0, "09000064b94736f1"], ["FEMA-2026-0002-0053", "FEMA", "FEMA-2026-0002", "Proposed Flood Hazard Determinations", "Notice", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-11-19", "2026-11-20 04:59:59", 0, "2026-08-21 17:04:23", "2026-17075", 1, 0, "09000064b94736f4"], ["OSHA-2012-0005-0016", "OSHA", "OSHA-2012-0005", "Cadmium in General Industry Standard; Extension of the Office of Management and Budget\u2019s (OMB) Approval of Information Collection (Paperwork) Requirements", "Notice", "Request for Comments", "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 17:09:23", "2026-17151", 1, 0, "09000064b94737b7"], ["FEMA-2026-0002-0056", "FEMA", "FEMA-2026-0002", "Proposed Flood Hazard Determinations", "Notice", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-11-19", "2026-11-20 04:59:59", 0, "2026-08-21 17:09:32", "2026-17074", 1, 0, "09000064b9473724"], ["BOEM-2026-0958-0001", "BOEM", "BOEM-2026-0958", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application to be Recognized as Qualified to Bid on, Hold, or Operate a Lease or Grant on the Outer Continental Shelf", "Notice", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 17:11:12", "2026-17149", 1, 0, "09000064b94738c2"], ["EPA-HQ-OW-2014-0359-0042", "EPA", "EPA-HQ-OW-2014-0359", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Information Request for the Underground Injection Control Program", "Notice", "Information Collection Request (ICR)", "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 17:53:22", "2026-17096", 1, 0, "09000064b94736ed"], ["CISA-2026-0166-0001", "CISA", "CISA-2026-0166", "Agency Information Collection Activities: The Department of Homeland Security, Emergency Communications Division, Communications Assets Survey and Mapping (CASM) Tool Registration Tool", "Notice", null, "2026-08-19", 2026, 8, "2026-08-19", "2026-10-19", "2026-10-20 03:59:59", 0, "2026-08-21 18:19:06", "2026-16877", 1, 0, "09000064b946a9df"], ["EPA-HQ-OPP-2022-0455-0011", "EPA", "EPA-HQ-OPP-2022-0455", "Pesticide Tolerances: Carboxin", "Rule", "Final Rule", "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 18:39:46", "2026-17088", 1, 0, "09000064b94736ee"], ["CMS-2026-2839-0001", "CMS", "CMS-2026-2839", "Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals and Supporting Regulations in 42 CFR 414.800-806 (CMS-10110)", "Notice", null, "2026-08-21", 2026, 8, "2026-08-21", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-21 18:45:44", "2026-17128", 1, 0, "09000064b94736f2"], ["EPA-HQ-OPP-2022-0743-0004", "EPA", "EPA-HQ-OPP-2022-0743", "Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Calcium Carbonate", "Rule", null, "2026-08-17", 2026, 8, "2026-08-17", "2026-10-16", "2026-10-17 03:59:59", 0, "2026-08-22 09:02:45", "2026-16720", 1, 0, "09000064b9461c65"], ["CMS-2026-2872-0001", "CMS", "CMS-2026-2872", "End Stage Renal Disease Medical Evidence Report Medicare Entitlement and/or Patient Registration (CMS-2728)", "Notice", null, "2026-08-22", 2026, 8, "2026-08-22", "2026-10-20", "2026-10-21 03:59:59", 0, "2026-08-22 18:47:51", "2026-17128", 1, 0, "09000064b94750de"], ["FAA-2026-8786-0001", "FAA", "FAA-2026-8786", "Airworthiness Directives: Airbus Helicopters", "Proposed Rule", "Request for Comment", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-08", "2026-10-09 03:59:59", 0, "2026-08-24 16:54:53", "2026-17209", 1, 0, "09000064b948c1ef"], ["FDA-2007-D-0369-2652", "FDA", "FDA-2007-D-0369", "PSG_020816 - Draft Guidance on Brinzolamide", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:08:40", null, 1, 0, "09000064b9470607"], ["FDA-2007-D-0369-2653", "FDA", "FDA-2007-D-0369", "PSG_020732 - Draft Guidance on Buprenorphine", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:08:45", null, 1, 0, "09000064b94706ae"], ["FDA-2007-D-0369-2654", "FDA", "FDA-2007-D-0369", "PSG_204370 - Draft Guidance on Cariprazine Hydrochloride", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:08:55", null, 1, 0, "09000064b94706b0"], ["FDA-2007-D-0369-2655", "FDA", "FDA-2007-D-0369", "PSG_050600 - Draft Guidance on Clindamycin Phosphate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:04", null, 1, 0, "09000064b94706b2"], ["FDA-2007-D-0369-2656", "FDA", "FDA-2007-D-0369", "PSG_215425 - Draft Guidance on Epinephrine", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:08", null, 1, 0, "09000064b94706b4"], ["FDA-2007-D-0369-2657", "FDA", "FDA-2007-D-0369", "PSG_218475 - Draft Guidance on Epinephrine Bitartrate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:13", null, 1, 0, "09000064b94706b6"], ["FDA-2007-D-0369-2658", "FDA", "FDA-2007-D-0369", "PSG_203565 - Draft Guidance on Ferric Carboxymaltose", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:18", null, 1, 0, "09000064b94706b8"], ["FDA-2007-D-0369-2659", "FDA", "FDA-2007-D-0369", "PSG_022180 - Draft Guidance on Ferumoxytol", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:23", null, 1, 0, "09000064b94706ba"], ["FDA-2007-D-0369-2660", "FDA", "FDA-2007-D-0369", "PSG_020243 - Draft Guidance on Fluvoxamine Maleate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:28", null, 1, 0, "09000064b94706bc"], ["FDA-2007-D-0369-2661", "FDA", "FDA-2007-D-0369", "PSG_020496 - Draft Guidance on Glimepiride", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:33", null, 1, 0, "09000064b94706be"], ["FDA-2007-D-0369-2662", "FDA", "FDA-2007-D-0369", "PSG_213876 - Draft Guidance on Hydrocortisone", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:38", null, 1, 0, "09000064b94706c0"], ["FDA-2007-D-0369-2663", "FDA", "FDA-2007-D-0369", "PSG_206185 - Draft Guidance on Latanoprost", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:09:42", null, 1, 0, "09000064b94706c2"], ["FDA-2007-D-0369-2664", "FDA", "FDA-2007-D-0369", "PSG_209939 - Draft Guidance on Letermovir", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:09", null, 1, 0, "09000064b94706c4"], ["FDA-2007-D-0369-2665", "FDA", "FDA-2007-D-0369", "PSG_021343 - Draft Guidance on Leuprolide Acetate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:14", null, 1, 0, "09000064b94706c6"], ["FDA-2007-D-0369-2666", "FDA", "FDA-2007-D-0369", "PSG_021379 - Draft Guidance on Leuprolide Acetate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:19", null, 1, 0, "09000064b94706c8"], ["FDA-2007-D-0369-2667", "FDA", "FDA-2007-D-0369", "PSG_021731 - Draft Guidance on Leuprolide Acetate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:24", null, 1, 0, "09000064b94706ca"], ["FDA-2007-D-0369-2668", "FDA", "FDA-2007-D-0369", "PSG_021924 - Draft Guidance on Levothyroxine Sodium", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:29", null, 1, 0, "09000064b94706cc"], ["FDA-2007-D-0369-2669", "FDA", "FDA-2007-D-0369", "PSG_215029 - Draft Guidance on Lidocaine", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:35", null, 1, 0, "09000064b94706ce"], ["FDA-2007-D-0369-2670", "FDA", "FDA-2007-D-0369", "PSG_021977 - Draft Guidance on Lisdexamfetamine Dimesylate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:41", null, 1, 0, "09000064b94706d0"], ["FDA-2007-D-0369-2671", "FDA", "FDA-2007-D-0369", "PSG_219847 - Draft Guidance on Lisdexamfetamine Dimesylate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:46", null, 1, 0, "09000064b94706d2"], ["FDA-2007-D-0369-2672", "FDA", "FDA-2007-D-0369", "PSG_219485 - Draft Guidance on Maralixibat Chloride", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:51", null, 1, 0, "09000064b94706d4"]], "truncated": false, "filtered_table_rows_count": 1133, "expanded_columns": [], "expandable_columns": [], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "comment_end_datetime", "perpetual_docket", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": [], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, comment_end_datetime, perpetual_docket, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from open_comments_active  limit 101", "params": {}}, "facet_results": {}, "suggested_facets": [], "next": "100", "next_url": "https://regs.datadawn.org/open_comments/open_comments_active.json?_next=100", "private": false, "allow_execute_sql": true, "query_ms": 1.448391005396843, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}